Grupo Televisa Files 13D/A on Apr 1 Grupo Televisa filed a Form 13D/A on Apr 1, 2026; SEC 5% threshold and a 10-day filing clock make this a material disclosure (Investing.com Apr 2, 2026).

Grupo Televisa Files 13D/A on Apr 1: Grupo Televisa filed a Form 13D/A on Apr 1, 2026; SEC 5% threshold and a 10-day filing clock make this a material disclosure (Investing.com Apr 2, 2026). 👈 Read full analysis #GrupoTelevisa #13DA #SEC #Investing #FinancialNews

Neumora Therapeutics 13D/A Filed on Apr 1 Form 13D/A filed Apr 1, 2026; 5% SEC disclosure threshold and 10-day amendment rule cited. Neumora's governance trajectory could alter R&D prioritization and partner options.

Neumora Therapeutics 13D/A Filed on Apr 1: Form 13D/A filed Apr 1, 2026; 5% SEC disclosure threshold and 10-day amendment rule cited. Neumora's governance trajectory could alter R&D prioritization and partner options. 👈 Read full analysis #NeumoraTherapeutics #SECfiling #13DA #biotech #investing

Cogent Biosciences Stake Rises to 5.4% After 13D/A Form 13D/A (Mar 31, 2026) reports 1,050,000 shares (5.4%) in Cogent Biosciences; filing flagged by Investing.com on Apr 1, 2026, elevating odds of strategic engagement.

Cogent Biosciences Stake Rises to 5.4% After 13D/A: Form 13D/A (Mar 31, 2026) reports 1,050,000 shares (5.4%) in Cogent Biosciences; filing flagged by Investing.com on Apr 1, 2026, elevating odds of strategic engagement. 👈 Read full analysis #CogentBiosciences #Investing #13DA #StockMarket #Finance

Some artwork inspired by Colin Baker's Big Finish Day panel.

#doctorwho #13da #doctorwhofanart #jodiewhittaker
@bigfinish.bsky.social @rafeski.bsky.social @oldsixie.bsky.social

Here's my alternate cover for: The Return of the Doctor!

First story was fantastic, so much characterisation for the both of them, Tim Foley does it again!

@bigfinish.bsky.social #doctorwho #fanart #doctorwhofanart #jodiewhittaker #mandipgill #13da